Mass Spectrometry Imaging Suggests That Cisplatin Affects Exocytotic Release by Alteration of Cell Membrane Lipids

Keyphrases

• Cisplatin 100%
• Mass Spectrometry Imaging 100%
• Cellular Lipids 100%
• Time-of-flight Secondary Ion Mass Spectrometry (ToF-SIMS) 75%
• Lipid Modification 75%
• Lipids 50%
• Exocytosis 50%
• Cisplatin Treatment 50%
• High Energy 25%
• Biological Samples 25%
• Signaling Pathway 25%
• Principal Coordinate Analysis (PCoA) 25%
• Cholesterol 25%
• Cell Surface 25%
• Neurotransmitter Release 25%
• PC12 Cells 25%
• Induced Apoptosis 25%
• Enhanced Sensitivity 25%
• Model Cell 25%
• Membrane Lipids 25%
• Cisplatin-induced 25%
• Phosphatidylcholine 25%
• Bimolecular 25%
• Lipid Content 25%
• Gas Cluster Ion Beam 25%
• Chemobrain 25%

Biochemistry, Genetics and Molecular Biology

• Cisplatin 100%
• Membrane Lipid 100%
• Mass Spectrometry Imaging 100%
• Lipid 85%
• Secondary Ion Mass Spectrometry 42%
• Anticancer 28%
• Exocytosis 28%
• Neurotransmitter Release 14%
• Principal Component Analysis 14%
• Lipid Composition 14%
• Programmed Cell Death 14%
• Lecithin 14%

Immunology and Microbiology

• Cell Membrane 100%
• Secondary Ion Mass Spectrometry 100%
• Imaging Mass Spectrometry 100%
• Exocytosis 66%
• Cell Surface 33%
• Lipid Composition 33%
• Neurotransmitter Release 33%
• PC12 Cell Line 33%
• Programmed Cell Death 33%